scispace - formally typeset
D

David A. Lenrow

Researcher at University of Pennsylvania

Publications -  35
Citations -  2710

David A. Lenrow is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Low back pain & Sacroiliac joint. The author has an hindex of 17, co-authored 35 publications receiving 2601 citations. Previous affiliations of David A. Lenrow include Hospital of the University of Pennsylvania.

Papers
More filters
Journal ArticleDOI

Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age.

TL;DR: It is concluded that increasing the serum testosterone concentrations of normal men over 65 yr of age to the midnormal range for young men decreased fat mass, principally in the arms and legs, and increased lean mass, chiefly in the trunk, but did not increase the strength of knee extension and flexion, as measured by dynamometer.
Journal ArticleDOI

Effects of testosterone replacement in hypogonadal men

TL;DR: It is concluded from this study that replacing testosterone in hypogonadal men increases bone mineral density of the spine and hip, fat-free mass, prostate volume, erythropoiesis, energy, and sexual function.
Journal ArticleDOI

Sacroiliac joint pain referral zones

TL;DR: Pain referral from the sacroiliac joint does not appear to be limited to the lumbar region and buttock, and a statistically significant relationship was identified between pain location and age, with younger patients more likely to describe pain distal to the knee.
Journal ArticleDOI

Etiologies of failed back surgery syndrome.

TL;DR: The epidemiologic data of nonsurgical and surgical etiologies of failed back surgery syndrome (FBSS) from two outpatient spine practices is reported to report the myriad of surgical and nonsurgical diagnoses from a nonsurgical perspective.
Journal ArticleDOI

A critical review of the evidence for the use of zygapophysial injections and radiofrequency denervation in the treatment of low back pain.

TL;DR: The evidence for the treatment of lumbar zygapophysial joint syndrome with intraarticular injections should be rated as level III (moderate) to IV (limited) evidence, whereas that for radiofrequency denervation is at a level III.